Abiopharma

🔍 Gilmer Daniel B. (Director)

Company: Armata Pharmaceuticals, Inc. (ARMP)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 51,280 shares of Stock Options (Right to Buy) at $12.92 per share (Derivative)
  Date: 2026-04-24 | Code: A | Expires: 2036-04-24 | equity_swap_involved: 0 | shares_owned_after: 51,280.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The Stock Option vests as to one-third of the underlying shares of common stock on each of the first, second and third annual anniversaries of the date of grant, subject to continuous service through the vesting date.